Everfront Biotech Inc.
PrivateLast Round
IPO
Jan 3, 2025
Total Funding Raised
$9.58M
Company Overview
Everfront Biotech Inc. operates in Healthcare & Life Sciences and is based in Taipei. Its latest recorded funding round was a Convertible Debt round in July 2023.
Everfront Biotech Inc. is a biotechnology company that develops orphan drugs for hard-to-treat diseases such as glioblastoma, pancreatic cancer, and amyotrophic lateral sclerosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical Devices
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Everfront Biotech Inc. Comparables
Compare Everfront Biotech Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NeOnc Technologies Holdings, Inc. | 83% | |
| Eisai | 82% | |
| NanOlogy, LLC | 77% |
For institutional investors. Book with your work email.
Everfront Biotech Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Jan 3, 2025 | ||||
| Convertible Debt | Jul 12, 2023 | ||||
| Grant | Sep 1, 2017 | ||||
| Grant | Dec 1, 2014 | ||||
| Grant | May 1, 2013 |
For institutional investors. Book with your work email.
Everfront Biotech Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ROTH Capital Partners | IPO |
| Sutter Securities, Inc. | IPO |
| The Benchmark Company | IPO |
| Ministry of Economic Affairs, Taiwan | Grant |
| Boustead Securities | IPO |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 3, 2025
$10M raised with ROTH Capital Partners and others.
- Jul 12, 2023
Raised $8M in convertible debt.
For institutional investors. Book with your work email.
Everfront Biotech Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Everfront Biotech Inc.'s valuation, stock price, and market status.
Is Everfront Biotech Inc. a public or private company?
Everfront Biotech Inc. is a private company.
What is the current stock price of Everfront Biotech Inc.?
Everfront Biotech Inc. is a private company, so its shares have no public market price. Caplight tracks Everfront Biotech Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Everfront Biotech Inc. worth (valuation)?
Valuation information for Everfront Biotech Inc. is not publicly available.
Can I buy Everfront Biotech Inc. stock?
Everfront Biotech Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Everfront Biotech Inc.'s last funding round?
Everfront Biotech Inc.'s most recent funding round was IPO on January 3, 2025.
Who are the main investors in Everfront Biotech Inc.?
Key investors in Everfront Biotech Inc. include ROTH Capital Partners, Sutter Securities, Inc., The Benchmark Company, Ministry of Economic Affairs, Taiwan, Boustead Securities.
Will Everfront Biotech Inc. IPO soon?
No public IPO plans have been announced for Everfront Biotech Inc..
How can I track Everfront Biotech Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Everfront Biotech Inc.'s shares on secondary markets.